Home A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjogren’s syndrome.
|

A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjogren’s syndrome.

Print
Share
Sign up for the
DRFZ NewsFlash